| CAT# | Product Name | M.W | Molecular Formula | Inquiry |
|---|---|---|---|---|
| C08052 | Bid BH3 Peptide | 2309.6 | ||
| C08056 | Bid BH3-R8 | 3616.2 | ||
| C08057 | Bid BH3-R9 | 3772.3 | ||
| C08058 | Bid-BH3 | 1839.1 | ||
| C08059 | Bik BH3 (50-70) | 2212.6 | ||
| C08060 | Bik BH3 (56-69) | 1490.8 | ||
| C08062 | Bim BH3 (87-100) | 1747 | ||
| C08064 | CEA Related, QYSWFVNGTF | 1248.4 | ||
| C08067 | Bim BH3, Peptide III | 3113.5 | ||
| C08070 | BMF BH3 peptide | 2401.8 | ||
| C08072 | BRCAA1 (610-619) | 1213.4 | ||
| C08073 | c-Myc peptide epitope | 1203.3 | ||
| C08074 | CEA , CAP-1, Carcinoembryonic Antigen | 964.1 | ||
| C08075 | CEA, CAP-1-6-D, [Asp6]-Carcinoembryonic Antigen | 965.1 | ||
| C08077 | Cell Penetrating Mutant ARF (37.44) Peptide | 2229.7 | ||
| C08078 | Cripto-1, CR-1 | 2037.8 | ||
| C08079 | F4.2, Gastric Signet Ring Cell Carcinoma Derived Peptide | 1303.5 | ||
| C08080 | CTT, Gelatinase Inhibitor | 1168.4 | ||
| C08081 | Cys-p21 (139.154) | 2101.4 | ||
| C08082 | E7 (43.62), HPV Oncoprotein | 2270.6 |
